Savara Inc (SVRA)

Dec 21, 2024

Wells Fargo Initiates Coverage of Savara (SVRA) with Overweight Recommendation - MSN

Dec 21, 2024

Dec 21, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 6,141 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 21, 2024

Dec 20, 2024

Savara: Rolling BLA Submission Of MOLBREEVI Generates Catalysts To Track (NASDAQ:SVRA) - Seeking Alpha

Dec 20, 2024

Dec 20, 2024

Savara (NASDAQ:SVRA) Now Covered by Analysts at Wells Fargo & Company - MarketBeat

Dec 20, 2024

Dec 19, 2024

Savara's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada

Dec 19, 2024

Dec 19, 2024

Savara's SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Dec 19, 2024

Dec 19, 2024

Savara (NASDAQ:SVRA) Shares Up 5.6%Time to Buy? - MarketBeat

Dec 19, 2024

Dec 19, 2024

BNP Paribas Financial Markets Purchases 18,534 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 19, 2024

Dec 19, 2024

JMP Securities Reiterates "Market Outperform" Rating for Savara (NASDAQ:SVRA) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Savara's MOLBREEVI Advances Toward First-Ever aPAP Treatment with FDA Rolling BLA Submission - StockTitan

Dec 18, 2024

Dec 17, 2024

Savara Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Dec 17, 2024

Dec 17, 2024

Savara to Present at J.P. Morgan Healthcare Conference: Rare Respiratory Disease Breakthroughs in Focus - StockTitan

Dec 17, 2024

Dec 17, 2024

Savara's CFO David Lowrance sells $83,277 in stock By Investing.com - Investing.com South Africa

Dec 17, 2024

Dec 17, 2024

The Manufacturers Life Insurance Company Acquires 3,706 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 17, 2024

Dec 17, 2024

Savara director Hawkins sells $26,568 in stock By Investing.com - Investing.com Australia

Dec 17, 2024

Dec 17, 2024

Savara director Hawkins sells $26,568 in stock - Investing.com India

Dec 17, 2024

Dec 16, 2024

Savara's SWOT analysis: molgramostim's promise buoys stock amid challenges - Investing.com

Dec 16, 2024

Dec 16, 2024

Savara Inc (NASDAQ:SVRA) CEO Matthew Pauls Sells 54,702 Shares - MarketBeat

Dec 16, 2024

Dec 16, 2024

Savara's CFO David Lowrance sells $83,277 in stock - Investing.com

Dec 16, 2024

Dec 16, 2024

Savara CEO Matthew Pauls sells $180,828 in stock - Investing.com

Dec 16, 2024

Dec 16, 2024

Savara CEO Matthew Pauls sells $180,828 in stock By Investing.com - Investing.com Australia

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Boosts Stake in Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 15, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Buys 642,259 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Dec 15, 2024

Dec 14, 2024

Janus Henderson Group PLC Decreases Stock Position in Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 14, 2024

Dec 13, 2024

Wellington Management Group LLP Acquires 1,608,522 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Dec 13, 2024

Dec 13, 2024

XChain, VARA’s Exclusive Transaction Monitoring Partner, Readies Rollout for Regional and Global VASPs - GlobeNewswire Inc.

Dec 13, 2024

Dec 07, 2024

Savara Inc (NASDAQ:SVRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 07, 2024

Dec 07, 2024

Intech Investment Management LLC Invests $174,000 in Savara Inc (NASDAQ:SVRA) - Defense World

Dec 07, 2024

Dec 05, 2024

Savara's SWOT analysis: molgramostim's promise lifts rare disease stock - Investing.com

Dec 05, 2024

Nov 30, 2024

Savara (NASDAQ:SVRA) Shares Down 3.2%Here's What Happened - MarketBeat

Nov 30, 2024

Nov 29, 2024

Savara Inc. Announces Stock Awards for New Employees - MSN

Nov 29, 2024

Nov 29, 2024

Savara Inc (NASDAQ:SVRA) Stock Holdings Lifted by Vestal Point Capital LP - MarketBeat

Nov 29, 2024

Nov 25, 2024

Connor Clark & Lunn Investment Management Ltd. Acquires 242,249 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Nov 25, 2024

Nov 22, 2024

Savara Grants 150,000 Share Inducement Awards to New Employees | SVRA Stock News - StockTitan

Nov 22, 2024

Nov 22, 2024

Savara Announces New Employment Inducement Grant - Business Wire

Nov 22, 2024

Nov 22, 2024

Savara to Present Phase 3 Trial Results for Breakthrough aPAP Treatment at BTS Meeting | SVRA Stock News - StockTitan

Nov 22, 2024

Nov 22, 2024

Jennison Associates LLC Acquires 1,001,296 Shares of Savara Inc (NASDAQ:SVRA) - MarketBeat

Nov 22, 2024

Nov 21, 2024

Independent Director of Savara Picks Up 4.5% More Stock - Simply Wall St

Nov 21, 2024

Nov 21, 2024

Savara Inc. Reports Third-Quarter Financial Results and Announces Key Regulatory Milestones - MSN

Nov 21, 2024

Nov 20, 2024

Insider Buying Alert: Joseph Mccracken Acquires 20,000 Shares of Savara Inc (SVRA) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

Savara director Joseph McCracken acquires $59,071 in common stock - Investing.com India

Nov 20, 2024

Nov 20, 2024

Savara director Joseph McCracken acquires $59,071 in common stock By Investing.com - Investing.com Canada

Nov 20, 2024

Nov 19, 2024

Director David Ramsay Acquires 100,000 Shares of Savara Inc (SVR - GuruFocus.com

Nov 19, 2024

Nov 18, 2024

Savara Inc director David Ramsay buys $287,600 in common stock - Investing.com

Nov 18, 2024

Nov 18, 2024

Savara Inc director David Ramsay buys $287,600 in common stock By Investing.com - Investing.com UK

Nov 18, 2024

Nov 15, 2024

Savara (NASDAQ:SVRA) Shares Down 8.5%Time to Sell? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Prudential Financial Inc's Strategic Acquisition of Savara Inc S - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

What is HC Wainwright's Estimate for Savara FY2024 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Evercore ISI Reiterates In-Line Rating for Savara (NASDAQ:SVRA) - Defense World

Nov 15, 2024

Nov 14, 2024

Savara (NASDAQ:SVRA) Reaches New 1-Year Low on Analyst Downgrade - MarketBeat

Nov 14, 2024

Nov 14, 2024

SVRA stock touches 52-week low at $3.27 amid market challenges - Investing.com India

Nov 14, 2024

Nov 13, 2024

500: Something went wrong - Investing.com Canada

Nov 13, 2024

Nov 13, 2024

Evercore Downgrades Savara on Manufacturing Concerns for Lung Disease Drug Candidate - GuruFocus.com

Nov 13, 2024